HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The preclinical and clinical activity of aviscumine: a potential anticancer drug.

Abstract
Extracts from the European mistletoe plant Viscumalbum have been studied for decades for their direct and indirect anticancer activity. Therefore, scientists were interested in identifying the active compound (mistletoe lectin) in these extracts and making it available as a highly purified molecule for drug development. Recombinant mistletoe lectin (INN: aviscumine) was produced in Escherichiacoli. It has been shown to have immunomodulatory and cytotoxic activity in invitro and in animal models and can target tumour cells. Clinical phase I studies also demonstrated immunomodulatory activity, which appears to have a positive effect on disease stabilisation. This review explores the current knowledge base for aviscumine's mechanism of action, efficacy and side-effects in both preclinical studies and clinical trials, and it considers aviscumine's potential as a cancer therapy.
AuthorsHeinz Zwierzina, Lothar Bergmann, Heiner Fiebig, Steinar Aamdal, Patrick Schöffski, Klaus Witthohn, Hans Lentzen
JournalEuropean journal of cancer (Oxford, England : 1990) (Eur J Cancer) Vol. 47 Issue 10 Pg. 1450-7 (Jul 2011) ISSN: 1879-0852 [Electronic] England
PMID21482461 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
CopyrightCopyright © 2011. Published by Elsevier Ltd.
Chemical References
  • Adjuvants, Immunologic
  • Antigens, CD
  • Antineoplastic Agents
  • Immunologic Factors
  • Plant Extracts
  • Plant Preparations
  • Recombinant Proteins
  • Ribosome Inactivating Proteins, Type 2
  • Toxins, Biological
  • ribosome inactivating protein, Viscum
  • Sialyltransferases
  • ST6GAL1 protein, human
Topics
  • Adjuvants, Immunologic (pharmacology)
  • Animals
  • Antigens, CD (metabolism)
  • Antineoplastic Agents (pharmacology)
  • Cell Line, Tumor
  • Clinical Trials as Topic
  • Drug Screening Assays, Antitumor (methods)
  • Escherichia coli (metabolism)
  • Humans
  • Immunologic Factors
  • Immunotherapy (methods)
  • Mice
  • Neoplasms (drug therapy, metabolism)
  • Plant Extracts (pharmacology)
  • Plant Preparations (pharmacology)
  • Protein Conformation
  • Rats
  • Recombinant Proteins (chemistry)
  • Ribosome Inactivating Proteins, Type 2 (pharmacology)
  • Sialyltransferases (metabolism)
  • Toxins, Biological (pharmacology)
  • Viscum album (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: